Develop new drugs,diagnostic and therapeutic algorithms to realize personalized treatment
Partner with online diagnosis and treatment platforms to develop new healthcare services
Apply the platform of Ping An Insurance (Group) Company of China to developing and selling new healthcare services
Partner with healthcare product suppliers, including drugmakers, on product selling & marketing
Develop an AI-based smart factory system to improve productivity and reliability of drug-making processes
Sales and Marketing
Develop the market for products developed by subsidiary companies as well as generics & OTC drugs introduced from other companies, and cooperate with present sales channels
Sell generics, OTC drugs, healthcare food and medical instruments to partner's platform and new customers
Negotiate with global suppliers on introduction of healthcare products
Plan the promotion strategies for products and services both at home and abroad held by the company
New Drug Development
Based on the world's top R&D activities of SHIONOGI & Co., Ltd. , we take the development of pharmaceuticals seeds and products as the main cause in China. We are playing a part in the public-related social concerns mentioned in the Health China 2030 Initiative, by offering the pharmaceuticals with added value praised highly.